Preclinical Evidence and Possible Mechanisms of Rhodiola rosea L. and Its Components for Ischemic Stroke: A Systematic Review and Meta-Analysis
Background:Rhodiola rosea L. has long been used as traditional medicines in Europe and Asia to treat a variety of common conditions and diseases including Alzheimer’s disease, cardiovascular disease, cognitive dysfunctions, cancer, and stroke. Previous studies reported that Rhodiola rosea L. and its...
Guardado en:
Autores principales: | Yan Li, Miao Cai, Gen-Xiang Mao, Qin-Fen Shu, Xiao-Bei Liu, Xiao-Li Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/572e50a216264480ab26735aeea931c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms
por: Kasper S, et al.
Publicado: (2017) -
Lack of salidroside impact on selected cytochromes encoding genes transcription in the liver of ethanol induced rats
por: Kujawski Radosław, et al.
Publicado: (2021) -
A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression
por: Bangratz M, et al.
Publicado: (2018) -
Estimation of reproductive toxicity of the complex plant remedy "Tireoton"
por: Y. G. Razuvaeva, et al.
Publicado: (2016) -
Bacteriemia por Kocuria rosea en un paciente con SIDA
por: Corti,Marcelo, et al.
Publicado: (2012)